NCT05489640View on ClinicalTrials.gov

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

July 17, 2024

Study Completion Date

July 17, 2024

Conditions
Hereditary Angioedema (HAE)
Interventions
OTHER

No Intervention

No Intervention will be administered in this study.

Trial Locations (1)

W2 6LA

Sciensus, London

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY